G16R (p.Gly16Arg) variant of JPH2 (Junctophilin-2)

G16R (p.Gly16Arg) in JPH2 (Junctophilin-2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.89 / 1. The record also includes population frequency data and structural context.

G16R (p.Gly16Arg) variant details